{"product_id":"the-comprehensive-guide-to-interdisciplinary-veterinary-social-work","title":"The Comprehensive Guide To Interdisciplinary Veterinary Social Work","description":"Designed for veterinarians, veterinary students, and vet techs, this essential guide bridges clinical medicine and emotional wellness to transform how you navigate difficult client conversations, ethical dilemmas, and team dynamics. Gain practical, evidence-based strategies for managing compassion fatigue, supporting grieving pet owners, and building resilient workplace cultures that protect both staff and patients. Through real-world case studies and actionable frameworks, discover how interdisciplinary social work strengthens the human-animal bond while safeguarding your own wellbeing. Instant digital download — start reading immediately.\n\n\u003ch3\u003eTable of Contents\u003c\/h3\u003e\n\u003cdiv class=\"gvc-locked-preview\"\u003e\n  \u003cdiv class=\"gvc-locked-icon\"\u003e🔒\u003c\/div\u003e\n  \u003ch3\u003eSample Preview\u003c\/h3\u003e\n  \u003cp\u003eThe full PDF is available after purchase. Instant download. Lifetime access. Read on any device.\u003c\/p\u003e\n  \u003cp class=\"gvc-locked-meta\"\u003eTrusted by 4,000+ veterinary professionals worldwide.\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cul\u003e\n  \u003cli\u003eContents (p.6)\u003c\/li\u003e\n  \u003cli\u003e1 Animal Welfare – Definition(s) (p.11)\u003c\/li\u003e\n  \u003cli\u003e2 Why and How Should We Assess Animal Welfare? (p.13)\u003c\/li\u003e\n  \u003cli\u003e3 On-Farm Animal Welfare Assessment (p.13)\u003c\/li\u003e\n  \u003cli\u003e4 Which Indicators Should We Use? (p.14)\u003c\/li\u003e\n  \u003cli\u003e5 Building a Welfare Assessment Protocol Step by Step (p.15)\u003c\/li\u003e\n  \u003cli\u003e6 CIISA’s Work with Farm Animal Welfare Assessment Protocols (p.18)\u003c\/li\u003e\n  \u003cli\u003e7 Final Comments (p.30)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.30)\u003c\/li\u003e\n  \u003cli\u003e1 Causing Pain in Farm Animals and Its Impact on Animal Welfare (p.35)\u003c\/li\u003e\n  \u003cli\u003e2 What Kind of Pain Are We Talking About? (p.37)\u003c\/li\u003e\n  \u003cli\u003e3 How to Recognize Pain During and After Routine Procedures? (p.39)\u003c\/li\u003e\n  \u003cli\u003e4 How to Manage Pain in Farm Animals – Constraints and Opportunities (p.41)\u003c\/li\u003e\n  \u003cli\u003e5 Research on the Most Important Sources of Pain in Farm Ruminants (p.43)\u003c\/li\u003e\n  \u003cli\u003e6 Conclusions (p.52)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.53)\u003c\/li\u003e\n  \u003cli\u003e1 The Origins of Creole Livestock (p.61)\u003c\/li\u003e\n  \u003cli\u003e2 Cattle (p.62)\u003c\/li\u003e\n  \u003cli\u003e3 Pigs (p.67)\u003c\/li\u003e\n  \u003cli\u003e4 Goats (p.70)\u003c\/li\u003e\n  \u003cli\u003e5 Horses (p.72)\u003c\/li\u003e\n  \u003cli\u003e6 Donkey (p.73)\u003c\/li\u003e\n  \u003cli\u003e7 Conclusions (p.74)\u003c\/li\u003e\n  \u003cli\u003e8 Future Perspectives (p.74)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.75)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.77)\u003c\/li\u003e\n  \u003cli\u003e2 Experimental Procedures (p.79)\u003c\/li\u003e\n  \u003cli\u003e3 Carcass Traits (p.79)\u003c\/li\u003e\n  \u003cli\u003e4 Meat Characteristics (p.83)\u003c\/li\u003e\n  \u003cli\u003e5 Sensory Attributes (p.85)\u003c\/li\u003e\n  \u003cli\u003e6 Genome-Wide Association Study (p.88)\u003c\/li\u003e\n  \u003cli\u003e7 Conclusions (p.90)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.91)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.95)\u003c\/li\u003e\n  \u003cli\u003e2 Hydrolysis of Structural Carbohydrates (p.96)\u003c\/li\u003e\n  \u003cli\u003e3 Mammalian Gut Fibrolytic Activity (p.97)\u003c\/li\u003e\n  \u003cli\u003e4 The Cellulosome (p.98)\u003c\/li\u003e\n  \u003cli\u003e5 The Cohesin-Dockerin Interaction (p.99)\u003c\/li\u003e\n  \u003cli\u003e6 Type I Coh-Doc Interactions and Cellulosome Assembly (p.101)\u003c\/li\u003e\n  \u003cli\u003e7 Type II Coh-Doc Interactions and Cellulosome Cell-Surface Attachment (p.105)\u003c\/li\u003e\n  \u003cli\u003e8 Ruminococcal Single-Binding Mode Type III Coh-Doc Interactions (p.106)\u003c\/li\u003e\n  \u003cli\u003e9 Cellulosome Diversity (p.108)\u003c\/li\u003e\n  \u003cli\u003e10 Biotechnological and Potential Applications for Cellulosomes (p.110)\u003c\/li\u003e\n  \u003cli\u003e11 Conclusions (p.110)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.111)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.117)\u003c\/li\u003e\n  \u003cli\u003e2 Carbohydrate-Active Enzymes (CAZymes) (p.117)\u003c\/li\u003e\n  \u003cli\u003e3 Carbohydrate-Binding Modules (CBMs) (p.119)\u003c\/li\u003e\n  \u003cli\u003e4 Anti-nutritive Properties of Non-starch Polysaccharides (NSPs) in Animal Nutrition (p.122)\u003c\/li\u003e\n  \u003cli\u003e5 Are Exogenous Enzymes Really Required for All Barley-Based Diets? (p.123)\u003c\/li\u003e\n  \u003cli\u003e6 Cellulases or β-Glucanases? What Are the Best Enzymes to Improve the Nutritive Value of Barley-Based Diets for Poultry? (p.125)\u003c\/li\u003e\n  \u003cli\u003e7 Role of CBMs in Exogenous Enzymes Used in Animal Nutrition (p.126)\u003c\/li\u003e\n  \u003cli\u003e8 Temporal Restriction of Exogenous Enzyme Supplementation (p.127)\u003c\/li\u003e\n  \u003cli\u003e9 Novel Insights into the Mechanism of Action of Feed Xylanases (p.129)\u003c\/li\u003e\n  \u003cli\u003e10 Conclusions (p.131)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.132)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.136)\u003c\/li\u003e\n  \u003cli\u003e2 Morphology and Phenology (p.140)\u003c\/li\u003e\n  \u003cli\u003e3 Chemical Composition and Nutritional Value (p.140)\u003c\/li\u003e\n  \u003cli\u003e4 Biological Activities (p.144)\u003c\/li\u003e\n  \u003cli\u003e5 Cistus ladanifer in Ruminant Diets (p.145)\u003c\/li\u003e\n  \u003cli\u003e6 Conclusions (p.162)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.162)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.170)\u003c\/li\u003e\n  \u003cli\u003e2 Pork Production and Quality (p.170)\u003c\/li\u003e\n  \u003cli\u003e3 Pork Production with Low Protein Diets (p.173)\u003c\/li\u003e\n  \u003cli\u003e4 Pork Production with Dietary Microalgae (p.177)\u003c\/li\u003e\n  \u003cli\u003e5 Conclusion and Future Perspectives (p.180)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.181)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.186)\u003c\/li\u003e\n  \u003cli\u003e2 The Lusitano Breed: A Brief Characterization (p.187)\u003c\/li\u003e\n  \u003cli\u003e3 Growth and Development of the Foal (p.191)\u003c\/li\u003e\n  \u003cli\u003e4 Final Remarks (p.200)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.201)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.207)\u003c\/li\u003e\n  \u003cli\u003e2 The In Situ and Ex Situ Preservation of Animal Genetic Resources (p.208)\u003c\/li\u003e\n  \u003cli\u003e3 Cryopreservation of Gametes and Embryos (p.209)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.217)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.224)\u003c\/li\u003e\n  \u003cli\u003e2 Work on Animal Seasonal Feed Restriction and Metabolism (p.225)\u003c\/li\u003e\n  \u003cli\u003e3 Work on Animal Health (p.231)\u003c\/li\u003e\n  \u003cli\u003e4 Work on Plant Adaptation to Hyperthermia and Draught Environments (p.232)\u003c\/li\u003e\n  \u003cli\u003e5 Work on Food Security and Rural Development (p.234)\u003c\/li\u003e\n  \u003cli\u003e6 Conclusion (p.236)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.236)\u003c\/li\u003e\n  \u003cli\u003e1 The Gut Microbiome (p.240)\u003c\/li\u003e\n  \u003cli\u003e2 Methods to Study the Gut Microbiome (p.241)\u003c\/li\u003e\n  \u003cli\u003e3 Gut Microbiome and Antimicrobial Resistance (p.243)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.247)\u003c\/li\u003e\n  \u003cli\u003e1 Urinary Tract Infections (p.253)\u003c\/li\u003e\n  \u003cli\u003e2 Pathophysiology and Predisposing Factors (p.254)\u003c\/li\u003e\n  \u003cli\u003e3 Classification of Urinary Tract Infections and Diagnosis (p.254)\u003c\/li\u003e\n  \u003cli\u003e4 Aetiology (p.255)\u003c\/li\u003e\n  \u003cli\u003e5 Antimicrobials for UTI Treatment in Companion Animals (p.256)\u003c\/li\u003e\n  \u003cli\u003e6 Antimicrobial Resistance Surveillance in Companion Animals (p.258)\u003c\/li\u003e\n  \u003cli\u003e7 Multidrug Resistance Bacteria Causing UTIs from Companion Animals (p.262)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.264)\u003c\/li\u003e\n  \u003cli\u003e1 The Antimicrobial Use in Veterinary Medicine (p.272)\u003c\/li\u003e\n  \u003cli\u003e2 Risk of Transfer of Antimicrobial-Resistant Bacteria (p.273)\u003c\/li\u003e\n  \u003cli\u003e3 Antimicrobial Resistance Mechanisms and Bacteria of Concern (p.274)\u003c\/li\u003e\n  \u003cli\u003e4 Enterobacteriaceae and Non-Enterobacteriaceae (p.277)\u003c\/li\u003e\n  \u003cli\u003e5 The Future (p.278)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.279)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.291)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.295)\u003c\/li\u003e\n  \u003cli\u003e2 Feline Immunodeficiency Virus (p.297)\u003c\/li\u003e\n  \u003cli\u003e3 Feline Coronavirus (p.299)\u003c\/li\u003e\n  \u003cli\u003e4 Virus Surveillance (p.300)\u003c\/li\u003e\n  \u003cli\u003e5 Virus and Marine Mammals (p.301)\u003c\/li\u003e\n  \u003cli\u003e6 Sea Turtles and Fibropapillomatosis (p.302)\u003c\/li\u003e\n  \u003cli\u003e7 Conclusion (p.303)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.303)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.322)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.344)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.352)\u003c\/li\u003e\n  \u003cli\u003e2 Material and Methods (p.352)\u003c\/li\u003e\n  \u003cli\u003e3 Quantitative Technique (p.353)\u003c\/li\u003e\n  \u003cli\u003e4 Qualitative Technique (p.354)\u003c\/li\u003e\n  \u003cli\u003e5 Faecal Cultures (p.355)\u003c\/li\u003e\n  \u003cli\u003e6 Scotch Tape Technique (p.358)\u003c\/li\u003e\n  \u003cli\u003e7 Macroscopic Examination (p.358)\u003c\/li\u003e\n  \u003cli\u003e8 Monitoring the Efficacy of Deworming Protocols (p.359)\u003c\/li\u003e\n  \u003cli\u003e9 Statistical Analysis (p.360)\u003c\/li\u003e\n  \u003cli\u003e10 Results and Discussion (p.361)\u003c\/li\u003e\n  \u003cli\u003e11 EPG Counts (p.362)\u003c\/li\u003e\n  \u003cli\u003e12 STOP Survey (p.363)\u003c\/li\u003e\n  \u003cli\u003e13 Intestinal Strongyles EPG Peaks (p.364)\u003c\/li\u003e\n  \u003cli\u003e14 Prevalence of Identified Parasites (p.365)\u003c\/li\u003e\n  \u003cli\u003e15 Faecal Cultures (p.368)\u003c\/li\u003e\n  \u003cli\u003e16 Parasite Control (p.368)\u003c\/li\u003e\n  \u003cli\u003e17 Conclusion (p.371)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.372)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.378)\u003c\/li\u003e\n  \u003cli\u003e2 Prions, the Great Villains (p.379)\u003c\/li\u003e\n  \u003cli\u003e3 The Bright Side of Prions (p.380)\u003c\/li\u003e\n  \u003cli\u003e4 Prions Are Forever (p.387)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.388)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.394)\u003c\/li\u003e\n  \u003cli\u003e2 The Notch Signaling Pathway (p.395)\u003c\/li\u003e\n  \u003cli\u003e3 Notch Enrolment in Mouse Post-natal Testis Development (p.395)\u003c\/li\u003e\n  \u003cli\u003e4 Notch Enrollment in Spermatogenesis (p.397)\u003c\/li\u003e\n  \u003cli\u003e5 Notch Enrolment in Ovarian Post-natal Development (p.399)\u003c\/li\u003e\n  \u003cli\u003e6 Notch Enrollment in Ovarian Follicular and Luteal Development (p.399)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.403)\u003c\/li\u003e\n  \u003cli\u003e1 The Notch Signalling Pathway (p.408)\u003c\/li\u003e\n  \u003cli\u003e2 Dll4 Signalling in Vascular Development (p.409)\u003c\/li\u003e\n  \u003cli\u003e3 Dll4 Signalling in Cancer Neoangiogenesis (p.412)\u003c\/li\u003e\n  \u003cli\u003e4 Targeting Dll4 Signalling in Cancer (p.414)\u003c\/li\u003e\n  \u003cli\u003e5 Exploring Dll4 Gain-of-Function as an Approach to Cancer Therapy (p.417)\u003c\/li\u003e\n  \u003cli\u003e6 A Potential Role for Dll4 Signalling in Metastasis Development (p.418)\u003c\/li\u003e\n  \u003cli\u003e7 Targeting Notch Signalling to Improve Physiological Angiogenesis (p.419)\u003c\/li\u003e\n  \u003cli\u003e8 Conclusion (p.420)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.420)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.424)\u003c\/li\u003e\n  \u003cli\u003e2 Clinical Presentation (p.426)\u003c\/li\u003e\n  \u003cli\u003e3 Treatment Options (p.427)\u003c\/li\u003e\n  \u003cli\u003e4 New Insights on the New Biomarkers: HER2 E CXCR4\/SDF-1 Axis (p.428)\u003c\/li\u003e\n  \u003cli\u003e5 Understanding the Role of miRNAs on FMC (p.431)\u003c\/li\u003e\n  \u003cli\u003e6 Exploring Efficacy of TKIs, HDACIs and MTIs in FMC (p.432)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.434)\u003c\/li\u003e\n  \u003cli\u003e1 Antibodies (Igs) as Immunotherapeutic Tools (p.441)\u003c\/li\u003e\n  \u003cli\u003e2 Selection and Screening of Recombinant Antibodies (p.444)\u003c\/li\u003e\n  \u003cli\u003e3 The New Generation of Recombinant Antibodies of Rabbit Origin (p.447)\u003c\/li\u003e\n  \u003cli\u003e4 Potential Applications of Rabbit Derived sdAbs (p.448)\u003c\/li\u003e\n  \u003cli\u003e5 Development of Specific Recombinant sdAbs Against gp120 HIV Glycoprotein (p.448)\u003c\/li\u003e\n  \u003cli\u003e6 Development of Recombinant Antibodies and Small Molecule Compounds for Diagnosis and Treatment of Naturally Occurring Canine Lymphoma (p.451)\u003c\/li\u003e\n  \u003cli\u003e7 Development of Recombinant sdAbs for Brain Targeting and Drug Delivery Across the Blood-Brain Barrier (p.455)\u003c\/li\u003e\n  \u003cli\u003e8 Conclusions (p.458)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.459)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.465)\u003c\/li\u003e\n  \u003cli\u003e2 Companion Animals in Clinical Research (p.466)\u003c\/li\u003e\n  \u003cli\u003e3 Canine Atopic Models (p.467)\u003c\/li\u003e\n  \u003cli\u003e4 Canine Atopic Dermatitis (p.470)\u003c\/li\u003e\n  \u003cli\u003e5 Canine Allergic Conjunctivitis (p.472)\u003c\/li\u003e\n  \u003cli\u003e6 Oral Squamous Cell Carcinoma Spontaneous Models (p.475)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.477)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.480)\u003c\/li\u003e\n  \u003cli\u003e2 In Vitro Ocular Membrane Permeation to EPO Protein (p.481)\u003c\/li\u003e\n  \u003cli\u003e3 Subconjunctival Administration in Physiologic Conditions (p.482)\u003c\/li\u003e\n  \u003cli\u003e4 Subconjunctival Administration in Glaucomatous Conditions (p.484)\u003c\/li\u003e\n  \u003cli\u003e5 Assessment of Functional and Structural Benefits of Subconjunctival EPO (p.485)\u003c\/li\u003e\n  \u003cli\u003e6 Limitations of the Study (p.485)\u003c\/li\u003e\n  \u003cli\u003e7 Future Directions (p.487)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.488)\u003c\/li\u003e\n  \u003cli\u003e1 Upper Airway Tract (p.490)\u003c\/li\u003e\n  \u003cli\u003e2 Lower Airway Tract (p.497)\u003c\/li\u003e\n  \u003cli\u003e3 Diagnostic (p.501)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.505)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.515)\u003c\/li\u003e\n  \u003cli\u003e2 Uteropathogenic E. Coli (p.516)\u003c\/li\u003e\n  \u003cli\u003e3 Host Defenses Against E. Coli Colonization of the Uterus (p.520)\u003c\/li\u003e\n  \u003cli\u003e4 Neutrophil Extracellular Traps (NETs) (p.525)\u003c\/li\u003e\n  \u003cli\u003e5 UtPEC and UPEC as a Zoonotic Risk (p.525)\u003c\/li\u003e\n  \u003cli\u003e6 Conclusions (p.526)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.526)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.533)\u003c\/li\u003e\n  \u003cli\u003e2 Endocrine Environment in the Endometrium (p.534)\u003c\/li\u003e\n  \u003cli\u003e3 Cytokines and Prostaglandins in Healthy Mare Endometrium (p.535)\u003c\/li\u003e\n  \u003cli\u003e4 Cytokines and Prostaglandins in the Unhealthy Endometrium (p.536)\u003c\/li\u003e\n  \u003cli\u003e5 Fibrosis in Mare Endometrium and Oviduct (p.537)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.541)\u003c\/li\u003e\n  \u003cli\u003e1 Definition and Aetiology (p.546)\u003c\/li\u003e\n  \u003cli\u003e2 Pathophysiology (p.547)\u003c\/li\u003e\n  \u003cli\u003e3 Clinical Signs (p.548)\u003c\/li\u003e\n  \u003cli\u003e4 Clinical Pathology (p.550)\u003c\/li\u003e\n  \u003cli\u003e5 Prognosis (p.551)\u003c\/li\u003e\n  \u003cli\u003e6 Treatment (p.553)\u003c\/li\u003e\n  \u003cli\u003e7 Prevention (p.556)\u003c\/li\u003e\n  \u003cli\u003e8 Conclusions (p.559)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.559)\u003c\/li\u003e\n  \u003cli\u003e\u003cem\u003e... and 37 more chapters\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003cdiv style=\"margin:20px 0;\"\u003e\n\u003ch3\u003ePreview This Book (First 20 Pages)\u003c\/h3\u003e\n\n\u003cp style=\"font-size:12px;color:#666;margin-top:4px;\"\u003eScroll through the preview above to see the first 20 pages of this book.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e🔗 Download Link:\u003c\/strong\u003e \u003c\/p\u003e","brand":"Global Vet \u0026 Co","offers":[{"title":"Default Title","offer_id":51233186709819,"sku":null,"price":350.0,"currency_code":"HKD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0948\/3062\/5083\/files\/the-comprehensive-guide-to-interdisciplinary-veterinary-social-work_HD.png?v=1780508163","url":"https:\/\/globalvetco.com\/products\/the-comprehensive-guide-to-interdisciplinary-veterinary-social-work","provider":"Global Vet \u0026 Co Ltd","version":"1.0","type":"link"}